Skip to content

Drug interactions

Efavirenz + Tamoxifen

Severity: Moderate

Efavirenz and Tamoxifen: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz is a CYP3A4 inducer, which can alter tamoxifen conversion to its metabolites, and its effect on endoxifen formation is uncertain. Possible reduced tamoxifen efficacy is a concern in breast cancer treatment.

What this interaction means in plain words

Efavirenz and Tamoxifen can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Tamoxifen belongs to Endocrine.

Evidence level: Low

Why it happens

Efavirenz modulates CYP3A4 and CYP2B6/2C9 activity involved in tamoxifen metabolism, with uncertain net effect on active metabolites.

What to do

Consider an antiretroviral not affecting CYP enzymes, such as an integrase inhibitor, if tamoxifen efficacy is critical. Otherwise monitor oncologic response closely.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Tamoxifen, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Tamoxifen?

MediHelp rates the interaction as moderate. Efavirenz and Tamoxifen can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz is a CYP3A4 inducer, which can alter tamoxifen conversion to its metabolites, and its effect on endoxifen formation is uncertain. Possible reduced tamoxifen efficacy is a concern in breast cancer treatment.

How serious is the interaction between Efavirenz and Tamoxifen?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider an antiretroviral not affecting CYP enzymes, such as an integrase inhibitor, if tamoxifen efficacy is critical. Otherwise monitor oncologic response closely.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in